TKT and chronic myelogenous leukemia, BCR-ABL1 positive: Chronic myeloid leukemia (CML) is a well-characterized myeloproliferative disorder, which results from dysregulated tyrosine kinase (TK) activity of the fusion oncoprotein BCR-ABL (16).